FDA updates providers on lymphoma risk associated with breast implants
The Food and Drug Administration yesterday updated health care providers about a type of lymphoma associated with breast implants and recommendations to inform patients about the risk and report, evaluate and treat the condition. Providers, patients and manufacturers have reported 457 cases of breast implant-associated anaplastic large cell lymphoma since 2010, including nine deaths. For more information, visit www.fda.gov.
Related News Articles
Blog
According to the CDC, 80% of pregnancy-related deaths can be prevented; that’s a 20% increase from previous years. Know why?
That’s actually the theme for…
#HealthCareInnovation Blog
By Marie Cleary-Fishman
Five years ago, a national effort began to ensure that health care for older adult patients is “age friendly.” This initiative — Age…
Headline
The Centers for Medicare & Medicaid Services and Centers for Disease Control and Prevention yesterday published a final rule that would update 1992…
News
In this case study, learn how New Jersey-based Hackensack Meridian Health successfully integrated behavioral health services across the health system by…
Headline
The National Institutes of Health yesterday awarded grants to five new projects through its Health Care Systems Research Collaboratory, which conducts clinical…
Insights and Analysis
Lawrence General Hospital Targets Food Insecurity Where It Counts
With social factors influencing up to 80 percent of health outcomes, hospitals are…